NEW YORK STOCK EXCHANGE, INC. · CLB
-0.68% · -$0.0900 · Vol 482.6K
Core Laboratories Inc

Core Laboratories Inc

Energy
$13.16

Veridion Score

Loading
Score loading…
Veridion Score History · 90D

Composite trend over time

LOADING HISTORY…
REFRESHES DAILY
AI Analysis
Sovereign

Why is CLB moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About Core Laboratories Inc
OIL & GAS FIELD SERVICES, NEC
Founded
Listed
1995
Employees
3K
HQ
US

Core Laboratories Inc is a providers of proprietary and patented reservoir description and production enhancement services and products to the oil and gas industry, through client relationships. The company operates its business in two segments; Reservoir Description, and Production Enhancement. It provides data and analytics to aid well operators in determining optimal methods for recovering, processing, and refining hydrocarbons from a well. It also manufactures the associated lab equipment for its services. The company generates majority of its revenue from Reservoir Description segment.

Key statistics

Real vendor fields plus Veridion-computed history. Missing fields stay blank.

Open
$13.11
Day high
$13.38
Day low
$13.11
Previous close
$13.25
52W high
$13.42
-1.94% from high
52W low
$13.16
0% of range
Market cap
$610.8M
P/E
EPS
Dividend yield
Beta
Shares out
46.1M
Float
Volume
482.6K
Avg volume
VWAP
$13.26
Next earnings
Price history computed in-house
1W
-1.94%
1M
-1.94%
3M
-1.94%
1Y
-1.94%
YTD
-1.94%
SMA 50 $13.30 · below
SMA 200 $13.30 · below
52W position 0%
Veridion warehouse edge

Warehouse intelligence for CLB.

Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.
Data ledger
Quote and day range
Refresh interval: 30 seconds
Source: Market data
Veridion Score
Coverage building
Chart and risk context
Daily bars with no missing-bar fill
Source: Market data
News and filings
Refresh intervals shown inside each panel
Source: Market news and federal filings
Financials
Loading quarterly statements…
SEC Form 4 ledger

CLB insider activity

Core Laboratories Inc

Score
Coverage building
Pressure
Net selling
Filings
11
Buys / sells
0 / 11
Net value
-$2.9M
Insiders
5
Named filers
TD
Tattoli Mark Damian
Insider
Leadership
GG
Gresham Gwendolyn
Insider
Leadership
BL
Bruno Lawrence
Insider
Leadership
Cluster

No multi-insider buying cluster in the last 90 days

Net pressure

Net selling: -$2.9M across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Filing dateTrade dateInsiderTitleTypePriceQtyOwnedValueReceipt
2026-05-042026-05-01Tattoli Mark DamianInsidersell$14.079727,514$1KSEC Form 4
2026-01-052025-12-31Tattoli Mark DamianInsidersell$16.0314,31027,361$229KSEC Form 4
2026-01-052025-12-31Gresham GwendolynInsidersell$16.0319,30133,226$309KSEC Form 4
2026-01-052025-12-31Bruno LawrenceInsidersell$16.03112,681257,438$1.8MSEC Form 4
2026-01-052025-12-31Hill Christopher ScottInsidersell$16.0332,152110,202$515KSEC Form 4
Full Form 4 history requires Sovereign

Showing 5 recent rows. Sovereign unlocks 6 additional rows, full sorting, and the named-filer history.

Upgrade to Sovereign · $25/mo
Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology
Congress · 90D
Loading PTR filings…
Federal contracts

CLB contract awards, year to date.

Public federal awards linked to this ticker.

Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for CLB in this window.
Lobbying spend

CLB lobbying filings, year to date.

Registered lobbying filings matched to Core Laboratories Inc.

Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for CLB in this window.
Latest news · CLB
Refresh interval: 5 minutes · Source: Market news insights
Loading articles…
Analyst ratings
Sovereign unlock shows live analyst consensus for CLB.
Options
Sovereign unlock shows live options positioning for CLB.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.